Today's Brief is inspired by Seth Godin's blog entitled How to talk about your project. We've taken the liberty of broadening Seth's focus from project to "life goals." Like Seth encourages his readers to look beyond marketing, we encourage you to think big picture, of purpose, life goals, and how you communicate them 'strategically, to yourself, your partners, your coaches and your investors (yes you have investors).'

Evidence is mounting that the US economy is not immune to the contagion of the global economic slowdown. The Commerce Department announced today that the US economy expanded at an anemic (seasonally adjusted) 0.7% in the fourth quarter. This compares to advances of 2% in third quarter and 3.9% in second quarter of last year. Some argue that seasonal adjustments currently used by government statisticians do not reflect the evolving economy, but it's hard to see how the economy escapes the downdrafts of global slowing, an unprecedented drop in oil prices and a surging dollar.

"People call it luck when you've acted more sensibly then they have." Amy Tan

When we invest or expend money to make a profit, we start from one of two vantages: Confidence or Luck. The first requires effort, competence, and a thorough understanding of what is controllable and what is not controllable and we plan contingencies for those things that are not controllable. The second perspective is the veritable flip a coin. Luck-dependent investment decisions are based on things like past performance, colorful brochures, and influential arguments.

We are big fans of Seth Godin at Beacon. As a marketing genius, his focus is centered in that industry, but many of his writings are much more broadly applicable. Not long ago a friend and client asked us to review an indexed life insurance product that his buddy, we'll call him Bob, was near zealous over. Bob was so enamored with the promises of the insurance policy that he was even considering changing careers to sell it. A change of some kind was forced on him because he had just been laid off at 50 from a high-level executive position with a major pharmaceutical firm.